Abstract | BACKGROUND: There is controversy as to whether haemodialysis-membrane biocompatibility (ie, the potential to activate complement and neutrophils) influences mortality of patients with acute renal failure. We did a prospective randomised multicentre trial in patients with dialysis-dependent acute renal failure treated with two different types of low-flux membrane. METHODS: FINDINGS: INTERPRETATION:
|
Authors | A Jörres, G M Gahl, C Dobis, M H Polenakovic, K Cakalaroski, B Rutkowski, E Kisielnicka, D H Krieter, K W Rumpf, C Guenther, W Gaus, J Hoegel |
Journal | Lancet (London, England)
(Lancet)
Vol. 354
Issue 9187
Pg. 1337-41
(Oct 16 1999)
ISSN: 0140-6736 [Print] England |
PMID | 10533862
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biocompatible Materials
- Membranes, Artificial
- Cellulose
- Polymethyl Methacrylate
- cuprammonium cellulose
|
Topics |
- APACHE
- Acute Kidney Injury
(classification, etiology, mortality, therapy)
- Biocompatible Materials
- Cellulose
(analogs & derivatives)
- Female
- Humans
- Logistic Models
- Male
- Membranes, Artificial
- Polymethyl Methacrylate
- Renal Dialysis
(instrumentation)
- Treatment Outcome
|